Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Knightscope Inc. ASRs Logging Hours, Making Names in Security

Knightscope is a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations. The company currently offers three autonomous robot (“ASR”) models – K1, K3 and K5, all of which can be remotely monitored through the Knightscope Security Operations Center (“KSOC”). Of the company’s innovative solutions, the K5 is Knightscope’s flagship fully autonomous, self-charging robot suitable for indoor and outdoor use. “It has nearly 1 million hours operating in the field and has already faced its fourth winter,” reads a recent article. “As recently as March 2021, Knightscope ASRs have made the news as an addition to transforming a northeast Las Vegas Valley apartment complex into a more peaceful place to live. ‘Westy’ is a K5 model patrolling the 1,129-unit Liberty Village apartment complex located just outside Nellis Air Force Base (https://ibn.fm/ibGYQ). Communicating in both English and Spanish, the autonomous security robot provides various security measures including verbal warnings, video recording, license plate reading and a phone-like connection with human security personnel. It has been especially useful in enforcing curfews and deterring vandalism, because ‘people don’t want to get caught on the cameras so they will avoid it,’ according to complex manager Carmen Batiz.”

To view the full article, visit https://ibn.fm/Fbf1E

About Knightscope

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Knightscope, Inc. | Leave a comment

MissionIRNewsBreaks – Brain Scientific Inc.’s (BRSF) Products Designed to Disrupt EEG Market

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has sought to narrow the wide access-to-neurological-care gap through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers. “By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool,” reads a recent article. As a result, the company has directly tackled the shortage of neurologists in the United States. “The company’s commercialized products were designed to disrupt the slow, expensive and cumbersome EEG market with easy-to-use, economical and disposable solutions. These devices are so easy to use that any medical professional can use them within minutes in any setting to run routine EEG studies.”

To view the full article, visit https://ibn.fm/WHmCv

About Brain Scientific Inc.

Brain Scientific is a commercial-stage health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Brain Scientific Inc. BRSF | Leave a comment

MissionIRNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Poised for Opportunity Amid Rising Demand

Uranium Energy (NYSE American: UEC) is positioned to benefit from the increased demand for low-cost and environmentally friendly uranium. This comes as the U.S. Democratic Party has changed its stand on nuclear energy for the first time since the Nixon administration in 1972. The move by the new administration bodes well for Uranium Energy. A recent article reads, “UEC has used and will be using in-situ recovery (‘ISR’) technology at its fully licensed projects. The company’s resource base of fully permitted ISR projects is the largest of any U.S.-based producer. These projects and the green technology they utilize have situated the company to capitalize on the world’s demand for more uranium and carbon-free energy.” The increased interest/demand has also positively impacted uranium stock, sending them “on a rebound after a downturn that has spanned many years.”

To view the full article, visit https://ibn.fm/YN5B9

About Uranium Energy Corp.

Uranium Energy is a U.S.-based uranium mining and exploration company. In South Texas, the company’s hub-and-spoke operations are anchored by the fully licensed Hobson Processing Facility, which is central to the Palangana, Burke Hollow and Goliad ISR projects. In Wyoming, UEC controls the Reno Creek project, which is the largest permitted, pre-construction ISR uranium project in the US Additionally, the company controls a pipeline of uranium projects in Arizona, New Mexico and Paraguay, a uranium/vanadium project in Colorado and a large, high-grade ferro-titanium project in Paraguay. The company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Uranium Energy Corp. UEC | Leave a comment

Brain Scientific Inc. (BRSF) Featured in Science and Technology Publication as Company Shaping the Future of Neurology Research

  • Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the future
  • Article details e-tattoo, BRSF’s solution that can capture big data in real-time about brain activity with possible applications in epileptic seizure predictions
  • E-tattoo could prove invaluable to medical researchers studying neurological conditions or even developers building brain-computer interfaces for mind-controlled electronics, video games

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has been featured in Neoscope as a company that champions cutting-edge research pushing the boundaries of what is possible in the brain diagnostics field (https://ibn.fm/IOD55). Neoscope is the publication of Futurism, a New York City-based media company concentrating on the scientific and technological advances for the future.

The article details Brain Scientific’s e-tattoo technology — a series of tiny electrodes stitched beneath the skin that can get a clear reading of neural signals in real-time. Although the e-tattoo could be used to develop brain-computer interfaces for virtual reality experiences or games controlled by neural signals or for mind-controlled electronics, the immediate use of this ground-breaking technology is primarily in the medical field.

The feature reports that Brain Scientific is exploring possibilities to use big data collected through e-tattoo to study the neurological precursor of epileptic seizures in patients. Whether there exists a typical pattern of brain waves before seizures occur would be invaluable information for doctors and patients alike. Still, the question remains unresolved so far. The article cites that Brain Scientific’s e-tattoo, however, could be a game-changer. E-tattoo would give researchers access to the wealth of real-time neurological data collected over a long time, something not possible to recreate in a lab.

“We are trying to predict when a seizure can happen,” Boris Goldstein, co-founder and executive chairman of Brain Scientific, told Futurism. “It is too still premature to say what the results will be, but these are more or less our goals: Just to predict when the seizure will happen so you can get medicine that might prevent it.”

Neoscope continues with a detailed description of the e-tattoo in the piece. E-tattoo is virtually invisible — electrodes the size of a hair are embedded under the skin, while a microEEG, as small as a postage stamp, is hidden behind the patient’s ear.

The article goes on to feature the graphene band, another brain diagnostics solution the Brain Scientific is currently developing. It can be imprinted onto the head like a “temporary tattoo” that can also read the same neural signals through the skin. Although less invasive and easier to remove, it will probably not provide the same level of access to the user’s brainwaves. It can be washed off with a special solvent instead of needing to be removed by a doctor, but herein lies its biggest flaw, too. Because it is not placed deep into the skin, it would not capture real signals only, which means that the data it collects would likely be affected by noise.

With a wealth of neural signals collected in real-time, e-tattoo could prove invaluable to medical researchers studying neurological conditions and tech developers of the future building brain-computer interfaces. The article concludes that whatever findings emerge from the epilepsy research, this immense amount of neurological data is a real treasure trove bound to reveal new, to this day, unknown or unresolved secrets of the human brain. Redefining what is possible, Brain Scientific is determined to tackle critical challenges in neurology by bringing these breakthrough findings to patient’s neurological care.

For more information, visit the Company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Brain Scientific Inc. BRSF | Leave a comment

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Reports Promising Preliminary Q1 2021 Results Indicating Momentum towards Attainment of Full-Year Targets

  • Nextech recently announced preliminary Q1 2021 results in which it reported over 200% increases in both revenue and gross profits compared to a similar period last year
  • Nextech is targeting revenue of between CA$50-$60 million for FY 2021, and the company intends to reach this target by launching a number of new products
  • Nextech had already launched some of the planned products in Q1 2021
  • The preliminary results are likely indications of the influence of the fulfilled launches and that the company is on course to realize its targets

In a presentation to investors during the Virtual Investor Conferences earlier this year, Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) founder and CEO Evan Gappelberg intimated that the company was targeting revenue of CA$50-60 million for FY2021. To achieve this target, Evan delineated “catalysts” in the form of planned launches that would include an ad network, new major brands for its e-commerce division, new augmented reality (“AR”) technology that facilitates holoportation and a standalone AR room product (https://ibn.fm/xgz5c).

As at the end of the first quarter of 2021, on March 31, the company had already launched its Ad Network and a holoportation feature on its AiR Show app that beams a live human hologram. Perhaps indicative of the influence these launches have already had on the company, the prevailing momentum towards realizing its targets for the full-year 2021, as well as the existing room for even more growth, Nextech reported promising preliminary Q1 2021 financial results on April 29 (https://ibn.fm/nKFY6).

Per the unaudited results, Nextech’s estimated Q1 2021 revenue is up nearly 208% to between $7.5-$7.7 million compared to revenue of $2.5 million for a similar period in 2020. Further, the company’s gross profits for the three months ended March 31, 2021, are estimated at between $4.1-$4.3 million, representing an increase of 193-207% compared to the $1.4 million reported for Q1 2020. The preliminary value of total bookings for Q1 2021 stands at $2.2 million.

“We are unique in that we are diversified with four fast-growing businesses, which all have a red thread of augmented reality connecting them, creating a major product differentiation and competitive advantage,” said Evan in a statement accompanying the preliminary results announcement. “We are strategically positioned with our AR, e-commerce and Inferno AR video conferencing and virtual experience business units to thrive in this new economy being led by a digital transformation across technology.”

Evan observed that the present age had presented more business opportunities for sectors in which Nextech has a foothold, namely virtual conferences, virtual events, e-commerce, AR and virtual learning. This effectively means that the company should benefit significantly by capitalizing on these opportunities through the coming period. NTAR foresees the strong business trends in each of these sectors continuing through the second quarter of 2021 and beyond, underscoring that the subsequent reporting periods will possibly witness equally significant financial results and growths.

Nextech expects to release the audited financial statements on or around May 13, 2021.

For more information, visit the company’s website at www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Nextech AR Solutions Corp. NEXCF | Leave a comment

MissionIRNewsBreaks – Infobird Co. Ltd. (NASDAQ: IFBD) Featured in Exclusive Broadcast

Infobird (NASDAQ: IFBD)  today announced the availability of a broadcast titled, “China Is Next Frontier in SaaS Revolution.” The piece discusses Infobird’s positioning as one of the few software-as-a-service (“SaaS”) companies in China with the capability to transition into a standard SaaS business model and serve both mid-to-large enterprises and SMEs by leveraging its no-code development platform. According to the audio press release, “A leading SaaS provider of patented, innovative AI-powered, customer-engagement solutions in China, the company earned its stripes by creating and delivering customized SaaS solutions for some of the largest commercial banks in the nation. Coming off a successful IPO, Infobird is now expanding its target market and rolling out standardized SaaS modules to service a myriad of other enterprises.”

To view the full press release, visit https://ibn.fm/Qq2PM

About Infobird Software Co. Ltd.

Infobird, headquartered in Beijing, China, is a software-as-a-service provider of innovative AI-powered or enabled customer engagement solutions. For more information about the company, visit www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Infobird Software Co. Ltd. IFBD | Leave a comment

MissionIRNewsBreaks – Amesite Inc. (NASDAQ: AMST) Founder, CEO Featured Guest on RedChip Money Report Interview

Amesite (NASDAQ: AMST), an artificial intelligence software company providing offering a cloud-based platform and content creation services for business, university and K-12 learning and upskilling, has announced that founder and CEO Dr. Ann Marie Sastry will be the featured guest speaker on a recent interview to be broadcast on “The RedChip Money Report(R),” which offers commentary on small-cap investing as well as interview with executives of public companies. The  interview is scheduled for broadcast on Bloomberg TV on Saturday, May 8, 2021, at 7 p.m. local times; the broadcast will reach 73 million homes in the United States. In addition, the interview is available on YouTube. During her interview, Sastry talks about recent developments and milestones for Amesite, an innovative company that is focused on bringing schools and universities into the digital age.

To view the full interview, visit https://ibn.fm/wyxUj

To view the full press release, visit https://ibn.fm/Bdit1 

About Amesite Inc.

Amesite is a high-tech artificial intelligence software company offering a cloud-based platform and content creation services for business, university and K-12 learning and upskilling. Amesite-offered courses and programs are branded to our customers. For more information about the company, please visit www.Amesite.com.

NOTE TO INVESTORS:The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Amesite Inc. AMST | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference/Webcast to Discuss Q1 Results, Provide Clinical Pipeline Update

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that it will host a conference call and live webcast to discuss its first quarter 2021 results and provide an update on its clinical pipeline. The event is scheduled to take place at 5:30 p.m. ET on Thursday, May 13, 2021. Interested parties may visit https://ibn.fm/nuO3H to register, as well as join the call by dialing 888-506-0062 (Toll-Free) or 973-528-0016 (International) and entering code: 396394. Participants are asked to dial in approximately five to 10 minutes before the beginning of the call.

To view the full press release, visit https://ibn.fm/GQFak

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Launches ‘Covid-ID Lab’ POC Pilot Project in Germany

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced its commencement of a pilot project with its rapid COVID-19 PCR test (“Covid-ID Lab”) in a point-of-care (“POC”) setting in Germany. Covid-ID Lab was recently approved in Europe and offers the accuracy of a PCR test in only 25 minutes. Validated work flows, including mobile collection and processing of patient samples, will be further optimized during the test. XPhyto’s clinical partner for the project is Spitzweg Apotheke, a well-known pharmacy in Langen near Frankfurt, Germany, currently running a COVID-19 test center at a clinic, where it also provides special pharmacy services for cancer patients. “With a specialized oncology pharmacy, many of our customers are in the COVID-19 high-risk group. For these patients, their families and their close contacts, fast and reliable diagnostics are critical to ensure everyday safety,” said Gabor Perl, head of the Spitzweg pharmacy. “PCR tests are the diagnostic gold standard for COVID-19. They provide high sensitivity and specificity. We are pleased to take part in this pilot project and now offer our high-risk-group customers access to a rapid PCR test with immediate results. We believe this is an opportunity for best-in-class health care delivery.”

To view the full press release, visit https://ibn.fm/08U8s

About XPhyto Therapeutics Corp.

XPhyto Therapeutics works with the most promising disrupters in the pharmaceutical industry; accelerates research and technology development; and commercializes products with an entrepreneurial approach and a commitment to efficiency, effectiveness and accessibility. The company’s network spans Europe and North America, with companies at the forefront of diagnostics and drug formulations, and universities specializing in research on the use of psychedelics and cannabinoids. To learn more, visit the company’s website at www.Xphyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR.NE) (FSE: N29) to Release Financial Report, Host Earnings Webcast

Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) (NEO: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) and its Virtual Experience Platform (“VXP”), has announced that it will release its Q1 2021 financial results next week, on May 12. In addition, the company also announced it will host a conference call with interested parties to discuss the financial report. The call will also be held on May 12, 2021, beginning at 5:30 p.m. ET. During the call, Nextech CEO Evan Gappelberg and chief financial officer Kashif Malik will talk about highlights from the report; the two will also participate in a Q&A session. Anyone interested in participating on the call can call (877) 201-0168, or (647) 788-4901 for international callers; conference call ID is 4288924. A webcast link is also available for the call. A recording of the webcast will be available on the company website following the event.

To view the full webcast, visit https://ibn.fm/T7eS3

To view the full press release, visit https://ibn.fm/K0X0T

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality (“AR”) platforms that transports three-dimensional (“3D”) product visualizations, human holograms and 360° portals to its audiences altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences. Nextech focuses on developing AR solutions however most of the Company’s revenues are derived from three e-Commerce platforms: vacuumcleanermarket.com (“VCM”), infinitepetlife.com (“IPL”) and Trulyfesupplements.com (“TruLyfe”). VCM and product sales of residential vacuums, supplies and parts, and small home appliances sold on Amazon. For more information about the company, please visit www.NextechAR.com.    

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Nextech AR Solutions Corp. NEXCF | Leave a comment